Shedir Pharma Group
Researches, develops, and commercializes health and wellness products.
SHE | XMIL
Overview
Corporate Details
- ISIN(s):
- IT0005379620
- LEI:
- 81560092B300849E9017
- Country:
- Italy
- Address:
- VIA BAGNULO, 95, 80063 PIANO DI SORRENTO
- Sector:
- Manufacturing
Description
Shedir Pharma Group specializes in the research, development, formulation, and commercialization of health and wellness products. The company's portfolio encompasses nutraceuticals, dermocosmetics, medical devices, and pharmaceuticals. A key focus is on innovation, resulting in the creation of unique and patented product formulations that cover approximately 15 therapeutic areas. The group operates through specialized subsidiaries that manage the entire product lifecycle, from initial research and intellectual property to marketing and distribution. Products are offered in various forms, such as capsules, tablets, powders, liquids, and gels, targeting professionals in the medical and pharmaceutical sectors.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-04-29 16:45 |
Assemblea ordinaria degli Azionisti del 29 aprile 2024
|
Italian | 548.3 KB | ||
| 2024-04-24 17:07 |
Comunicato deposito lista collegio sindacale
|
Italian | 585.6 KB | ||
| 2024-04-12 17:32 |
Pubblicazione avviso di convocazione Assemblea ordinaria degli Azionisti
|
Italian | 404.7 KB | ||
| 2024-04-12 17:30 |
Deposito della Relazione Finanziaria Annuale 2023 e della documentazione assemb…
|
Italian | 507.0 KB | ||
| 2024-03-29 18:09 |
SHEDIR PHARMA BILANCIO 2023 - RICAVI (+10,3%) ED EBITDA (+9,6%) RISPETTO AL 2022
|
Italian | 969.8 KB | ||
| 2024-01-29 16:29 |
SHEDIR PHARMA GROUP - CALENDARIO EVENTI SOCIETARI 2024
|
Italian | 481.7 KB | ||
| 2023-09-29 17:39 |
Shedir Pharma Group - AL 30 GIUGNO 2023 FATTURATO ED EBITDA CONSOLIDATI IN NETT…
|
Italian | 527.0 KB | ||
| 2023-09-25 18:26 |
AGGIORNAMENTO SULL’ESECUZIONE DEL PROGRAMMA DI ACQUISTO AZIONI PROPRIE
|
Italian | 493.6 KB | ||
| 2023-09-18 17:00 |
AGGIORNAMENTO SULL’ESECUZIONE DEL PROGRAMMA DI ACQUISTO AZIONI PROPRIE
|
Italian | 492.2 KB | ||
| 2023-09-11 17:21 |
AGGIORNAMENTO SULL’ESECUZIONE DEL PROGRAMMA DI ACQUISTO AZIONI PROPRIE
|
Italian | 492.2 KB | ||
| 2023-09-04 17:10 |
AGGIORNAMENTO SULL’ESECUZIONE DEL PROGRAMMA DI ACQUISTO AZIONI PROPRIE
|
Italian | 492.2 KB | ||
| 2023-08-28 16:07 |
AGGIORNAMENTO SULL’ESECUZIONE DEL PROGRAMMA DI ACQUISTO AZIONI PROPRIE
|
Italian | 491.5 KB | ||
| 2023-07-31 15:16 |
AGGIORNAMENTO SULL’ESECUZIONE DEL PROGRAMMA DI ACQUISTO AZIONI PROPRIE
|
Italian | 492.0 KB | ||
| 2023-06-29 18:35 |
Nomina nuovo Nominated Adviser (NOMAD)
|
Italian | 472.6 KB | ||
| 2023-06-19 17:32 |
AGGIORNAMENTO SULL’ESECUZIONE DEL PROGRAMMA DI ACQUISTO AZIONI PROPRIE
|
Italian | 517.2 KB |
Automate Your Workflow. Get a real-time feed of all Shedir Pharma Group filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Shedir Pharma Group
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Shedir Pharma Group via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
